What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
Nicholas P. Restifo spends much of his time researching Immunology, Cytotoxic T cell, Antigen, Immunotherapy and T cell.
His work deals with themes such as Cancer and Cancer research, Melanoma, which intersect with Immunology.
His studies deal with areas such as Molecular biology, CD8 and Cytokine as well as Cytotoxic T cell.
His Antigen research includes elements of Antibody and Virology.
His work on Cancer immunotherapy and Cancer vaccine as part of general Immunotherapy study is frequently linked to Natural selection, therefore connecting diverse disciplines of science.
Nicholas P. Restifo combines subjects such as Interleukin 2 and Dendritic cell with his study of T cell.
His most cited work include:
- Cancer immunotherapy: moving beyond current vaccines. (2543 citations)
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2452 citations)
- Cancer regression in patients after transfer of genetically engineered lymphocytes (2174 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Immunotherapy, T cell, Cytotoxic T cell and Antigen.
Nicholas P. Restifo interconnects Cancer research and Melanoma in the investigation of issues within Immunology.
His Cancer research study combines topics in areas such as Interleukin 12 and Cytokine.
His Immunotherapy research is multidisciplinary, relying on both Interleukin 2 and Oncology.
In his study, Cellular differentiation is strongly linked to Cell biology, which falls under the umbrella field of T cell.
His biological study spans a wide range of topics, including Molecular biology and Virology.
He most often published in these fields:
- Immunology (56.89%)
- Immunotherapy (32.00%)
- T cell (30.89%)
What were the highlights of his more recent work (between 2014-2021)?
- T cell (30.89%)
- Cancer research (28.67%)
- Immunotherapy (32.00%)
In recent papers he was focusing on the following fields of study:
Nicholas P. Restifo mainly focuses on T cell, Cancer research, Immunotherapy, Immunology and Adoptive cell transfer.
The study incorporates disciplines such as Cell biology, Effector, CD8 and Cytokine in addition to T cell.
His CD8 research is multidisciplinary, incorporating perspectives in Cytotoxic T cell and Tyrosine kinase.
The concepts of his Immunotherapy study are interwoven with issues in Melanoma, Oncology and Antigen.
The Immunology study combines topics in areas such as Reprogramming and Disease.
He has researched Adoptive cell transfer in several fields, including Antibody, Tumor-infiltrating lymphocytes, Cell therapy and Interleukin 15.
Between 2014 and 2021, his most popular works were:
- Adoptive cell transfer as personalized immunotherapy for human cancer. (1238 citations)
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response (412 citations)
- Identification of essential genes for cancer immunotherapy (370 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
His scientific interests lie mostly in Immunotherapy, Immunology, T cell, Cancer research and Adoptive cell transfer.
Immunology is closely attributed to Cancer in his work.
Nicholas P. Restifo has included themes like Epigenetics, CD8 and Cell biology in his T cell study.
He combines subjects such as Tumor microenvironment, Cytotoxic T cell and Chromatin with his study of CD8.
His Cancer research research is multidisciplinary, incorporating elements of Effector, Cancer immunotherapy and T-cell receptor.
His biological study spans a wide range of topics, including Oncology, Antigen, Internal medicine, Melanoma and Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
